The Nigeria Centre for Disease Control (NCDC) says Dexamethasone has not been approved or validated as treatment for coronavirus.
NCDC said it was aware of recent outcomes from a United Kingdom funded clinical trial for COVID-19.
“The results support the use of Dexamethsaone as a possible treatment to reduce the risk of death among COVID-19 patients, who require oxygen or mechanical ventilation,” the NCDC said.
Adding that, “Please note that the Government of Nigeria has not validated or approved any treatment for COVID-19.
“In addition, the use of Dexamethasone for COVID-19 treatment has not been validated by the World Health Organisation.
NCDC pointed out that, “We are aware of ongoing clinical trials conducted by scientists in the UK and will work with our sister agencies to evaluate this emerging data on the use of Dexamethasone.
“We will inform the general public on outcomes following scientific review and validation,” the Centre for Disease Control said.
